← OxalateWatch   All posts

A Common CKD Medication and Kidney Stones: What the New Data Shows

2026-08-19 · By Elena Novak, Research Editor · Dietary reference, not medical advice

A medication that helps protect kidney function in some patients may have an under-recognized side effect, according to a real-world study published on August 18, 2026 in Scientific Reports (a Nature journal). The finding matters for a specific group — adults with chronic kidney disease and type 2 diabetes — and it is worth understanding even if you are reading this as a food-reference site and not a medication guide.

The finding, plainly: Researchers compared adults who started finerenone (a non-steroidal mineralocorticoid receptor antagonist) against matched patients starting three other common CKD drug classes. Over the follow-up window, finerenone initiators had a higher rate of new kidney stone diagnoses — a 32.8% higher risk versus spironolactone, 48.3% versus SGLT2 inhibitors, and 49.5% versus ACE inhibitors or ARBs.

What the Study Actually Did

The team used the TriNetX US Collaborative Network, pulling a new-user cohort from June 2021 to June 2024. Finerenone initiators were matched one-to-one against people starting spironolactone, SGLT2 inhibitors, or ACE inhibitors/ARBs, and the primary outcome was a new nephrolithiasis diagnosis in the 4 to 16 months after starting. The hazard ratios were 1.328 (95% CI 1.065-1.657) versus spironolactone, 1.483 (1.118-1.967) versus SGLT2 inhibitors, and 1.495 (1.145-1.953) versus ACEi/ARB. The association held across subgroups, including those with diabetes and hypertension.

The contrast that stands out is the SGLT2-inhibitor side. Those drugs have shown a stone-protective signal in earlier work, and here finerenone appeared to work against that signal when the two were combined. None of this establishes causation — it is an observational, real-world comparison — but it is a signal large enough to flag.

Why This Connects to a Food Database

Two lessons carry over to the diet side. First, kidney stone risk is never just about food — it is food plus medication plus hydration plus the underlying condition, and a person with CKD and diabetes already sits at the intersection of several stone risks. Second, the diet and fluid habits that matter for stones are the same ones a person on any of these drugs still needs: enough water, controlled sodium, and modest animal protein. The medication question itself belongs to the prescribing doctor, not to a food database.

The boundary, stated clearly: this page describes research, not a treatment recommendation. Do not start, stop, or change any medication because of this article. If you take finerenone or any CKD drug and have a stone history, raise the question with your doctor.

Stone-Friendly Habits, Measured

The diet and fluid habits that support stone prevention stay the same regardless of medication:

FoodOxalate (mg)ServingRating
Lemonade2 mg1 cupSafe
Watermelon2 mg1 cup cubedSafe
Chicken breast, roasted0 mg4 ozSafe
Cheese, hard and soft1 mg1 ozSafe
Spinach590 mg1 servingAvoid

The pattern is familiar: low-oxalate produce, dairy, and modest protein sit safe, while the high-oxalate greens need portion awareness. Water stays the single highest-value habit, whatever else is in the picture.

Frequently Asked Questions

Should I stop my CKD medication because of this study?
No. This is one observational study, not a reason to change treatment. Medication decisions belong to your doctor, who weighs your whole picture — including kidney function and diabetes control — against any single risk signal.
What can I do on the food side while on these medications?
The same stone-prevention basics apply: drink enough water to keep urine pale, keep sodium in check, and keep animal protein moderate. These habits help regardless of what medication you are on.
Sources:
Harvard T.H. Chan School of Public Health Oxalate Database (2024); USDA FoodData Central; Chen YH, Hwang TL, Lu ZH, et al. "Risk of nephrolithiasis with finerenone versus other chronic kidney disease medications." Scientific Reports (2026). DOI 10.1038/s41598-026-65475-8. All oxalate values are lab-measured via ion chromatography. This page is a dietary reference tool, not medical advice.

See how oxalate values are measured and verified on our data methodology page.

Medical Disclaimer: This site is a dietary reference tool based on published food composition data. It does not provide medical advice, diagnose, or treat any condition. Talk to your doctor or a registered dietitian before changing your diet, especially if you have kidney stones, kidney disease, or other medical conditions.